Thus, increased ADAM15 expression in airway myofibroblasts may promote small airway fibrosis in patients with COPD by increasing the activation and survival of (myo) fibroblasts and/or their release of pro-fibrotic mediators. This evidence concerns the gene ADAM15 and chronic obstructive pulmonary disease.